Annovis Bio (ANVS)
(Delayed Data from NYSE)
$9.14 USD
+1.16 (14.54%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $9.10 -0.04 (-0.44%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth A Momentum B VGM
Annovis Bio, Inc. (ANVS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$38.17 | $72.00 | $13.00 | 378.32% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Annovis Bio, Inc. comes to $38.17. The forecasts range from a low of $13.00 to a high of $72.00. The average price target represents an increase of 378.32% from the last closing price of $7.98.
Analyst Price Targets (6 )
Broker Rating
Annovis Bio, Inc. currently has an average brokerage recommendation (ABR) of 1.57 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the seven recommendations deriving the current ABR, five are Strong Buy, representing 71.43% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.57 | 1.57 | 1.67 | 1.67 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
7/11/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
7/2/2024 | Rodman & RenshawCo. | Elemer Piros | Not Available | Strong Buy |
5/3/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Hold |
4/30/2024 | Canaccord Genuity | Sumant Kulkarni | Strong Buy | Strong Buy |
3/1/2024 | LadenburgThalmann | Aydin Huseynov | Strong Buy | Strong Buy |
2/28/2024 | Brookline Capital Markets | Tyler Bussian | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.57 |
ABR (Last week) | 1.57 |
# of Recs in ABR | 7 |
Average Target Price | $38.17 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | -0.64 |
ANVS FAQs
Annovis Bio, Inc. (ANVS) currently has an average brokerage recommendation (ABR) of 1.57 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Annovis Bio, Inc. (ANVS) is $43.20. The current on short-term price targets is based on 3 reports.
The forecasts for Annovis Bio, Inc. (ANVS) range from a low of $21 to a high of $72. The average price target represents a increase of $372.65 from the last closing price of $9.14.
The current UPSIDE for Annovis Bio, Inc. (ANVS) is 372.65%
Based on short-term price targets offered by six analysts, the average price target for Annovis Bio, Inc. comes to $38.17. The forecasts range from a low of $13.00 to a high of $72.00. The average price target represents an increase of 378.32% from the last closing price of $7.98.